They are intended for the qualitative detection and differentiation of IgM (developed early during infection) and IgG (developed late during infection) antibodies to SARS-CoV-2 in serum, plasma or venipuncture whole blood specimens from patients suspected of COVID-19 by a healthcare provider. The gene discussed is CD40LG; the disease is infection.